Cellectis - ADR Live Share Price Today, Share Analysis and Chart
about
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the fi...
Read More34,616 XNAS Volume
XNAS 05 May, 2025 3:31 PM (EDT)
Low Financial Strength
Mid Valuation
Technically Neutral
Await Turnaround
These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks.
View Similar
Embed DVM
Cellectis - ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..